These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2885890)

  • 21. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
    Baker LA; Cheng LY; Amara IB
    Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia.
    Mori K; Nagao M; Yamashita H; Morinobu S; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):659-65. PubMed ID: 15276691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients.
    Valevski A; Modai I; Zbarski E; Zemishlany Z; Weizman A
    Clin Neuropharmacol; 1998; 21(6):355-7. PubMed ID: 9844793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of negative schizophrenic symptoms with trihexyphenidyl.
    Tandon R; Greden JF; Silk KR
    J Clin Psychopharmacol; 1988 Jun; 8(3):212-5. PubMed ID: 3379147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: The effect of benztropine mesylate on plasma levels of butaperazine maleate.
    el-Yousef MK; Manier DH
    Am J Psychiatry; 1974 Apr; 131(4):471-2. PubMed ID: 4149998
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model.
    Singh MM; Kay SR
    Neuropsychobiology; 1979; 5(2):74-86. PubMed ID: 34804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticataleptic effect of taurine: interaction with antiparkinsonian agents.
    Zebrowska-Lupina I; Porowska A
    Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA; Milanes F; Starkey T; Slater V; Dominguez F
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract]   [Full Text] [Related]  

  • 32. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of benztropine mesylate on the prolactin response to haloperidol.
    Halbreich U; Sachar EJ; Nathan RS; Asnis GM; Halpern FS
    Psychopharmacology (Berl); 1980; 72(1):61-5. PubMed ID: 6781007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of benztropine on the diurnal prolactin responses to haloperidol.
    Nathan RS; Perel JM; McCarthy T; Jarrett DB
    Psychoneuroendocrinology; 1985; 10(1):71-6. PubMed ID: 3889966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamics of the serum pipothiazine level in patients with schizophrenia during long-term treatment with this neuroleptic agent].
    Lipska B; Szukalski B; Nurowska K; Welbel L
    Psychiatr Pol; 1987; 21(1):14-9. PubMed ID: 2887001
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute effects of lisuride (0.1 mg), amantadine (100 mg) and trihexyphenidyl (5 mg) on verbal associations.
    Hrbek J; Komenda S; Macáková J; Vinar O; Dostálová K; Komárková A
    Act Nerv Super (Praha); 1978 Feb; 20(1):78. PubMed ID: 636788
    [No Abstract]   [Full Text] [Related]  

  • 39. The rate, pattern, and cost of use of antiparkinsonian agents among patients treated for schizophrenia in a managed care setting.
    Ascher-Svanum H; Kennedy JS; Lee D; Haberman M
    Am J Manag Care; 2004 Jan; 10(1):20-4. PubMed ID: 14738183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postnatal development of benztropine-induced locomotor stimulation: evidence for an anticholinergic mechanism of action.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):313-20. PubMed ID: 4734004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.